Controversy Surrounding World Association of Transgender Medicine Revealed in Internal Video
A recent video obtained by Environmental Progress sheds light on the controversial practices of the World Association of Transgender Medicine (WPATH) in providing gender-affirming care to minors. The video, from a panel titled “Evolution Workshop Identity” held on May 6, 2022, revealed that members of the Association are struggling to adequately inform young patients about the consent process for hormonal interventions.
Canadian endocrinologist Daniel Metzger discussed the challenges he faces in obtaining consent from adolescents seeking medical treatment, stating that many patients lack basic medical understanding of the effects of such interventions, even adults. This raises concerns about the informed consent process for minors, as these treatments could result in lifelong implications such as sterility.
Despite presenting itself as a scientific group with standards of care based on expert knowledge, WPATH’s practices have been called into question. The video reveals that the group does not follow rigorous scientific processes in determining treatment protocols, with President Marci Bowers admitting in a forum that the impact of puberty blockers on sexual function and fertility is not fully understood.
Critics argue that the Association is advocating for unregulated experiments on vulnerable young people, with members accused of being activists disguised as doctors. The publication in Environmental Progress highlights instances where patients experienced complications from hormone treatments, raising concerns about the lack of oversight and ethical standards in the field of transgender medicine.
As debates surrounding gender-affirming care continue to unfold, it is essential for medical professionals and organizations to prioritize the well-being and safety of patients, especially minors. The revelations from the leaked video have sparked further scrutiny of WPATH and its practices, prompting calls for greater transparency and accountability in the field of transgender medicine.